The Court of Appeal in Paris has ruled that Sanofi must pay 150.7 million euros to CNAM as compensation for anti-competitive practices related to the drug Plavix.
Matei Gaginsky
International
Foto: Sylvain ROBIN / Alamy / Profimedia
Always see our news on Google
The court's decision is based on a ruling from 2013, when Sanofi was fined 40.6 million euros for actions against generic drug manufacturers. The court found that the impact of these practices persisted until 2021, although the anti-competitive behavior lasted only five months. CNAM will receive 126.2 million euros for reimbursements and fees, plus 24.5 million euros in damages. Sanofi is reviewing the ruling and considers the possibility of an appeal to the Supreme Court.
Sources
Latest News
23:21
The option of a technocratic government could return to the negotiating table. Ciprian Ciucu: "The President would have tested one or two, three options, but I was not told what those options are."
22:53
The President of Brazil, Lula da Silva, is launching his campaign for a fourth term / He declares himself to be "in excellent shape" at the age of 80.
22:17
Radu Miruță: "It is a complicated situation, a situation that is merely the consequence of poor management of the balance between electricity production and consumption / Romania, for years, has only shut down"
21:50
Fire on a ferry in Indonesia, off the coast of Madura Island: Five people have died and 41 are missing.
21:26
Superliga: Corvinul Hunedoara and Sepsi finished in a draw, 1-1
See more news
NEWS ON THE SAME TOPICS
Current Affairs
The Competition Council has fined five companies 6.42 million lei for limiting the sales of medical imaging equipment in Romania.
.webp)
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
